(B) the remaining amount shall be used to 
provide funding to community-based organiza-
tions that work with full-benefit dual eligible in-
dividuals (as so defined) in order to provide 
such education and outreach. 
(2) MONITORING IMPACT ON DUALS.— 
(A) IN
GENERAL.—$50,000,000 shall be 
used by the Centers for Medicare & Medicaid 
Services, in consultation with the Centers for 
Disease Control and Prevention, the Adminis-
tration on Aging, and the Social Security Ad-
ministration, to develop and implement a stand-
ardized protocol to collect data from health de-
partments and other sources in 10 representa-
tive urban and rural communities on the impact 
of the transition of full benefit dual eligible in-
dividuals (as so defined) from prescription drug 
coverage under the medicaid program to pre-
scription drug coverage under part D of the 
medicare program. Such protocol shall be im-
plemented by not later than July 1, 2005. 
(B) MONITORING.—The protocol developed 
under subparagraph (A) shall include for the 
monitoring of the following information with re-
spect to such full benefit dual eligible individ-
uals: 
(i) Emergency room visit rates. 
(ii) Hospitalization rates. 
(iii) Nursing home placement rates. 
(iv) Deaths. 
(C) COLLECTION BY PDPS AND MA–PDS.— 
The protocol developed under subparagraph (A) 
shall require that such data be collected by the 
prescription drug plans and the MA–PDs in 
which the individuals are enrolled and include 
information on race and ethnicity. 
(D) REPORTS.—Not later than January 1, 
2006, and July 1, 2006, the Administrator of 
the Centers for Medicare & Medicaid Services, 
in consultation with the Centers for Disease 
Control and Prevention, the Administration on 
Aging, and the Social Security Administration, 
shall submit a report to Congress on the imple-
mentation of the protocol under subparagraph 
(A). 
(b) NEW AMOUNTS.—There are appropriated to the 
Secretary of Health and Human Services, to be trans-
ferred from the Federal Hospital Insurance Trust Fund 
and the Federal Supplementary Medical Insurance Trust
Fund, for fiscal year 2005 and each subsequent fiscal 
year, an amount not to exceed $50,000,000 (or if greater, 
an amount equal to $1 multiplied by the number of indi-
viduals entitled to benefits under part A of title XVIII 
of the Social Security Act or enrolled under part B of such 
title for the year) in order to award grants to States under 
section 4360 of the Omnibus Budget Reconciliation Act 
of 1990 (42 U.S.C. 1395b–4). 
(c) EXTENSION OF AVAILABILITY OF AMOUNTS AP-
PROPRIATED UNDER MMA.—Section 1015(b) of the 
Medicare Prescription Drug, Improvement, and Mod-
ernization Act of 2003 (Public Law 108–173; 117 Stat. 
2446) is amended by striking ‘‘September 30, 2005’’ and 
inserting ‘‘September 30, 2006’’. 
SEC. 6. COLLECTION AND SHARING OF DUAL ELIGIBLE 
DRUG UTILIZATION DATA. 
(a) IN GENERAL.—Section 1860D–42 of the Social 
Security Act (42 U.S.C. 1395w–152) is amended by add-
ing at the end the following new subsection: 
‘‘(c) COLLECTION AND SHARING OF DUAL ELIGIBLE 
DRUG UTILIZATION DATA.— 
‘‘(1) PLAN REQUIREMENT.—A PDP sponsor of 
a prescription drug plan and an MA organization of-
fering an MA–PD plan shall submit to the Secretary 
such information regarding the drug utilization of
enrollees in such plans who are full-benefit dual eli-
gible individuals (as defined in section 1935(c)(6)) 
as the Secretary determines appropriate to carry out 
paragraph (2). 
‘‘(2) COLLECTION AND SHARING OF DATA.— 
The Secretary shall collect data on the drug utiliza-
tion of full-benefit dual eligible individuals (as so de-
fined). The Secretary shall share such data with the 
States and the District of Columbia in as close to 
a real-time basis as possible.’’. 
(b) EFFECTIVE DATE.—The amendment made by 
subsection (a) shall take effect as if included in the enact-
ment of section 101(a) of the Medicare Prescription Drug, 
Improvement, and Modernization Act of 2003 (Public Law 
108–173; 117 Stat. 2071). 
SEC. 7. GAO STUDY ON THE CLAWBACK FORMULA. 
(a) STUDY.— 
(1) IN GENERAL.—The Comptroller General of 
the United States shall conduct a study on the 
clawback formula contained in section 1935(c) of the 
Social Security Act (42 U.S.C. 1396u–5(c)), as 
added by section 103(b) of the Medicare Prescrip-
tion Drug, Improvement, and Modernization Act of 
2003 (Public Law 108–173; 117 Stat. 2155).